Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The THERAPY Trial: The Randomized, Concurrent Controlled Trial to Assess the Penumbra System's Safety and Effectiveness in the Treatment of Acute Stroke

NCT01429350 is registered in ClinicalTrials.gov with Penumbra Inc. as lead sponsor.

NCT NCT01429350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01429350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The THERAPY Trial: The Randomized, Concurrent Controlled Trial to Assess the Penumbra System's Safety and Effectiveness in the Treatment of Acute Stroke
Lead sponsor
Penumbra Inc.
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2012
Completion date
October 31, 2016
Enrollment
108 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke